tiprankstipranks
Nektar Therapeutics (MX:NKTR)
:NKTR
Mexico Market
NKTR
Nektar Therapeutics
RESEARCH TOOLSreports

Nektar Therapeutics (NKTR) Ratios

0 Followers

Nektar Therapeutics Ratios

MX:NKTR's free cash flow for Q2 2026 was $1.00. For the 2026 fiscal year, MX:NKTR's free cash flow was decreased by $ and operating cash flow was $-4.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 10.42 4.97 4.26 6.45 8.00
Quick Ratio
 10.42 4.97 4.26 6.14 7.72
Cash Ratio
 0.55 0.28 0.72 0.69 1.29
Solvency Ratio
 -0.82 -0.86 -0.47 -1.00 -1.03
Operating Cash Flow Ratio
 -3.29 -3.89 -2.86 -3.76 -4.46
Short-Term Operating Cash Flow Coverage
 -10.30 -10.17 0.00 0.00 0.00
Net Current Asset Value
$ 547.39M$ 75.69M$ 18.18M$ 63.66M$ 202.01M
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.53 0.34 0.30 0.19
Debt-to-Equity Ratio
 0.15 1.66 1.69 0.90 0.36
Debt-to-Capital Ratio
 0.13 0.62 0.63 0.47 0.26
Long-Term Debt-to-Capital Ratio
 0.06 0.41 0.00 0.00 0.00
Financial Leverage Ratio
 1.21 3.12 5.00 3.04 1.94
Debt Service Coverage Ratio
 -2.51 -2.93 -3.08 -9.59 -11.31
Interest Coverage Ratio
 -4.24 -4.99 -3.74 -5.42 -8.31
Debt to Market Cap
 0.04 0.12 0.00 0.00 0.00
Interest Debt Per Share
 5.05 10.38 9.53 11.30 12.86
Net Debt to EBITDA
 -0.72 -0.98 -0.67 -0.34 -0.13
Profitability Margins
Gross Profit Margin
99.36%100.00%68.82%59.34%76.50%
EBIT Margin
-247.17%-249.91%-92.54%-278.42%-365.08%
EBITDA Margin
-246.18%-248.05%-88.08%-269.75%-351.82%
Operating Profit Margin
-240.38%-236.77%-106.88%-152.49%-260.97%
Pretax Profit Margin
-287.13%-297.32%-121.10%-306.54%-396.48%
Net Profit Margin
-287.84%-297.07%-120.86%-306.31%-399.98%
Continuous Operations Profit Margin
-287.25%-297.07%-120.86%-306.31%-399.98%
Net Income Per EBT
100.24%99.92%99.80%99.93%100.88%
EBT Per EBIT
119.45%125.57%113.31%201.02%151.93%
Return on Assets (ROA)
-14.35%-58.51%-39.15%-69.36%-51.82%
Return on Equity (ROE)
-37.99%-182.65%-195.86%-210.75%-100.43%
Return on Capital Employed (ROCE)
-12.81%-57.64%-43.39%-39.63%-37.40%
Return on Invested Capital (ROIC)
-12.53%-52.82%-40.02%-37.52%-36.34%
Return on Tangible Assets
-14.35%-58.51%-39.15%-69.36%-58.07%
Earnings Yield
-6.41%-23.00%-62.20%-257.00%-87.06%
Efficiency Ratios
Receivables Turnover
 11.48 31.05 61.17 40.02 10.95
Payables Turnover
 0.01 0.00 2.65 3.72 1.67
Inventory Turnover
 0.00 0.00 0.00 2.28 1.13
Fixed Asset Turnover
 12.82 11.04 8.32 2.44 1.07
Asset Turnover
 0.05 0.20 0.32 0.23 0.13
Working Capital Turnover Ratio
 0.09 0.27 0.41 0.24 0.15
Cash Conversion Cycle
 -26.15K 11.76 -131.54 71.41 138.29
Days of Sales Outstanding
 31.80 11.76 5.97 9.12 33.32
Days of Inventory Outstanding
 0.00 0.00 0.00 160.38 323.95
Days of Payables Outstanding
 26.18K 0.00 137.50 98.09 218.98
Operating Cycle
 31.80 11.76 5.97 169.50 357.28
Cash Flow Ratios
Operating Cash Flow Per Share
 -7.07 -12.36 -12.82 -15.21 -24.37
Free Cash Flow Per Share
 -7.08 -12.37 -12.92 -15.27 -24.82
CapEx Per Share
 <0.01 0.01 0.11 0.07 0.45
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.01 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
 -892.32 -1.22K -119.69 -222.67 -53.56
Capital Expenditure Coverage Ratio
 -892.32 -1.22K -119.69 -222.67 -53.56
Operating Cash Flow Coverage Ratio
 -1.72 -1.40 -1.71 -1.64 -2.31
Operating Cash Flow to Sales Ratio
 -4.28 -3.78 -1.79 -2.14 -3.30
Free Cash Flow Yield
-11.00%-29.26%-92.63%-180.12%-73.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -11.07 -4.35 -1.61 -0.39 -1.15
Price-to-Sales (P/S) Ratio
 38.99 12.91 1.94 1.19 4.59
Price-to-Book (P/B) Ratio
 2.72 7.94 3.15 0.82 1.15
Price-to-Free Cash Flow (P/FCF) Ratio
 -9.09 -3.42 -1.08 -0.56 -1.37
Price-to-Operating Cash Flow Ratio
 -10.49 -3.42 -1.09 -0.56 -1.39
Price-to-Earnings Growth (PEG) Ratio
 -1.15 -0.36 0.03 0.01 0.04
Price-to-Fair Value
 2.72 7.94 3.15 0.82 1.15
Enterprise Value Multiple
 -16.56 -6.18 -2.88 -0.78 -1.44
Enterprise Value
 2.23B 847.09M 249.58M 189.91M 466.20M
EV to EBITDA
 -16.56 -6.18 -2.88 -0.78 -1.44
EV to Sales
 40.76 15.34 2.54 2.11 5.06
EV to Free Cash Flow
 -9.51 -4.06 -1.41 -0.98 -1.51
EV to Operating Cash Flow
 -9.52 -4.06 -1.42 -0.99 -1.53
Tangible Book Value Per Share
 27.32 5.32 4.43 10.34 23.26
Shareholders’ Equity Per Share
 27.32 5.32 4.43 10.34 29.39
Tax and Other Ratios
Effective Tax Rate
 >-0.01 <0.01 <0.01 <0.01 >-0.01
Revenue Per Share
 1.65 3.27 7.18 7.11 7.38
Net Income Per Share
 -4.75 -9.73 -8.68 -21.79 -29.51
Tax Burden
 1.00 1.00 1.00 1.00 1.01
Interest Burden
 1.16 1.19 1.31 1.10 1.09
Research & Development to Revenue
 2.41 2.12 1.23 1.27 2.37
SG&A to Revenue
 0.98 1.24 0.78 0.86 1.00
Stock-Based Compensation to Revenue
 0.22 0.23 0.22 0.37 0.62
Income Quality
 1.49 1.27 1.48 0.70 0.83
Currency in USD